drugset / Trial / NCT02479529

Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.

NCT02479529 ↗

Phase 3 Completed 130 enrolled Centre Hospitalier Universitaire, Amiens
RandomizedParallel-groupOpen-labelTreatment

Summary

After cardiac surgery, vasoplegic syndrome is a hemodynamic state characterized by profound hypotension associated with a decrease in systemic vascular resistance. The care of this disease is based on the intravenous administration of a vasopressor, usually norepinephrine. During the recovery phase, weaning of norepinephrine, is an important step in which any lack of preload (blood volume) initial or secondary can be, and increase tissue malperfusion.

Timeline

Start
2014-10
Primary completion
2016-06
Completion
2016-06

Outcome

Met primary endpoint

paper The cumulative duration of norepinephrine treatment after inclusion was shorter in the intervention group than in the control group PMID 28120005 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified — Intravenous

Indications

No indication recorded.